Dysregulated glucagon secretion from pancreatic alpha-cells is a key feature of type-1 and type-2 diabetes (T1D and T2D), yet our mechanistic understanding of alpha-cell function is underdeveloped relative to insulin-secreting beta-cells. Here we show that the enzyme acetyl-CoA-carboxylase 1 (ACC1), which couples glucose metabolism to lipogenesis, plays a key role in the regulation of glucagon secretion. Pharmacological inhibition of ACC1 in mouse islets or αTC9 cells impaired glucagon secretion at low glucose (1 mmol/l). Likewise, deletion of ACC1 in alpha-cells in mice reduced glucagon secretion at low glucose in isolated islets, and in response to fasting or insulin-induced hypoglycaemia in vivo. Electrophysiological recordings identifie...
Acetyl-CoA carboxylase (ACC) catalyzes the production of malonyl-CoA which may act as a metabolic co...
Aims/hypothesis Glucagon is critical for normal glucose homeostasis and aberrant secretion of the ho...
Insulin-induced hypoglycemia is a major treatment barrier in type-1 diabetes (T1D). Accordingly, it ...
Dysregulated glucagon secretion from pancreatic alpha-cells is a key feature of type-1 and type-2 di...
Aims: One of the hallmarks of diabetes is dysregulated glucagon secretion from pancreatic alpha cell...
Aims/hypothesis: Pancreatic beta cells secrete insulin to maintain glucose homeostasis, and beta cel...
Aims: ACC1 couples glucose metabolism with de novo lipogenesis in lipogenic tissues, by converting a...
Aims: Acetyl-coA Carboxylase 1 (ACC1) is an enzyme that couples glucose metabolism with de novo lip...
Glucagon secretion by pancreatic α-cells is triggered by hypoglycemia and suppressed by high glucose...
Acetyl-CoA carboxylase (ACC) catalyzes the carboxylation of acetyl-CoA to produce malonyl-CoA, the m...
AIMS/HYPOTHESIS: Glucagon release from pancreatic alpha cells is required for normal glucose homoeos...
Background and aims: An intra-islet incretin system has been recently suggested to operate through m...
Acetyl-CoA carboxylase (ACC) catalyzes the production of malonyl-CoA which may act as a metabolic co...
Aims/hypothesis Glucagon is critical for normal glucose homeostasis and aberrant secretion of the ho...
Insulin-induced hypoglycemia is a major treatment barrier in type-1 diabetes (T1D). Accordingly, it ...
Dysregulated glucagon secretion from pancreatic alpha-cells is a key feature of type-1 and type-2 di...
Aims: One of the hallmarks of diabetes is dysregulated glucagon secretion from pancreatic alpha cell...
Aims/hypothesis: Pancreatic beta cells secrete insulin to maintain glucose homeostasis, and beta cel...
Aims: ACC1 couples glucose metabolism with de novo lipogenesis in lipogenic tissues, by converting a...
Aims: Acetyl-coA Carboxylase 1 (ACC1) is an enzyme that couples glucose metabolism with de novo lip...
Glucagon secretion by pancreatic α-cells is triggered by hypoglycemia and suppressed by high glucose...
Acetyl-CoA carboxylase (ACC) catalyzes the carboxylation of acetyl-CoA to produce malonyl-CoA, the m...
AIMS/HYPOTHESIS: Glucagon release from pancreatic alpha cells is required for normal glucose homoeos...
Background and aims: An intra-islet incretin system has been recently suggested to operate through m...
Acetyl-CoA carboxylase (ACC) catalyzes the production of malonyl-CoA which may act as a metabolic co...
Aims/hypothesis Glucagon is critical for normal glucose homeostasis and aberrant secretion of the ho...
Insulin-induced hypoglycemia is a major treatment barrier in type-1 diabetes (T1D). Accordingly, it ...